In mammals, the umbilical cord connects the embryo or fetus to the fetal site of the placenta. It contains two arteries and one vein, which are embedded in gelatinous connective tissue (Wharton's jelly) consisting of collagen fibers, myofibroblast-like stroma cells, and proteoglycans (Can and Karahuseyinoglu 2007; Takechi et al. 1993) . Both the umbilical cord vein and arteries are lined by a single layer of endothelial cells, which is directly adjacent to the muscularis layer in the umbilical arteries and separated by a thin elastic subintima layer in the umbilical vein (Benirschke and Kaufmann 2000) . The muscularis layer consists of an inner longitudinal and an outer circular muscle layer (Zhang S-X 1999) . The umbilical vein conducts oxygen, nutrients, and various other substances from the mother to the fetus, whereas the umbilical arteries transport waste materials away from the fetus back to the maternal circulation. The actual exchange of metabolic products between the fetal and maternal circulation occurs in the placenta at the syncytiotrophoblast level. Immunoglobulin G (IgG) is one of the substances that is transferred across the placental barrier (Pitcher-Wilmott et al. 1980) to confer passive immunity to the fetus. Following its transfer across the syncytiotrophoblast layer, IgG is subsequently transported via the umbilical vein to the fetus. The transplacental transfer of IgG is thought to be mediated by the neonatal Fc receptor (FcRn) expressed in syncytiotrophoblasts (Roopenian and Akilesh 2007) . It is currently not known whether FcRn is also expressed in the umbilical cord. However, the expression of Fc gamma receptors (FcγRs) has previously been studied in the human umbilical cord by Sedmak et al. (1991) and Lang et al. (1993) , who found FcγRs only expressed on immune cells but not on endothelial cells.
Most of the IgG present in the fetal circulation is thought to be produced by the mother (Gitlin and Biasucci 1969) .
However, a small portion of the IgG circulating in the fetus expresses a non-maternal haplotype. This non-maternal IgG could in part have its origin in the placenta because trophoblasts are capable of producing IgG, which has been demonstrated in a previous study conducted by our group (Zhao Y, Deng R, Chen Z, Korteweg C, Zhang J, Li J,Wang Yun, Wang Yongyu, Lin C, Bluth MH, Niu N, Zhuang Z, Su M, Gu J, unpublished data) . In that study, various experiments, including conventional in situ hybridization (ISH), combined immune electron microscopy ISH, and laser capture microdissection followed by RT-PCR on placental tissues and a primary trophoblast cell line, showed the presence of IgG at the mRNA level in trophoblasts, strongly indicating that such cells can produce IgG (Zhao Y, Deng R, Chen Z, Korteweg C, Zhang J, Li J,Wang Yun, Wang Yongyu, Lin C, Bluth MH, Niu N, Zhuang Z, Su M, Gu J unpublished data). In view of the close anatomical relationship between the placenta and the umbilical cord and their common derivation from the same zygote, we hypothesized that cells of the umbilical cord might also synthesize IgG. Using ISH and RT-PCR on umbilical cord tissues and a primary umbilical endothelial cell culture system, we show here that human umbilical endothelial cells (HUECs) have the ability to produce IgG. We also demonstrated mRNA expression of the recombination activating genes -1 and -2 (RAG1 and RAG2) in HUECs. Finally, FcRn was detected on HUECs, whereas none of the FcγR subclasses was expressed on HUECs.
Materials and Methods

Tissues, Sections, and Cell Lines
Umbilical cord tissues were obtained from 10 full-term healthy pregnant women from the first affiliated Hospital of the Medical College of Shantou University (Shantou, P.R. China). All of the samples were divided into two parts. One part of the samples was cut into 1 × 0.5-cm 2 specimens washed in PBS, fixed in 4% formalin overnight, and then embedded in paraffin. The sections were cut at the right angle to the long axis of the umbilical cord. The endothelial cells were cut across their entire thickness, which is generally about 3 to 5 µm in length. The tissue sections were prepared at 4 µm thick according to the routine procedure of paraffin sections for immunohistochemistry (IHC) and ISH in our laboratory. The other portion of the samples was cut into small pieces and washed carefully until the suspension became translucent in preparation for RNA extraction of human umbilical cord tissues. The connective tissue adjacent to the large blood vessels was dissected from the umbilical cord and served as a negative control. Primary-cultured human umbilical vein endothelial cells (HUVECs) were a gift from Professor Nanping Wang, Institute of Cardiovascular Science, Peking University (Beijing, P.R. China). This study was in accordance with the Helsinki Declaration, and the procedures were approved by the Research Administrative Committee of Peking University.
To compare the expression levels of IgG in HUVECs with those in pre-and mature B lymphocytes, we used two cell lines-that is, the human pre-B cell line (NALM-6) and Burkitt lymphoma cell line (Raji), respectively. They were cultured in RPMI 1640 (GIBCO, Carlsbad, CA) containing 10% FBS at 37C in a humidified atmosphere with 5% CO 2 and were subjected to the same tests as for the endothelial cells.
Human Umbilical Vein Endothelial Cell Preparation
Collagenase treatment was performed to isolate HUVECs, and the cells were cultured on plates coated with collagen (Holland et al. 1988; Jaffe et al. 1973; Wang et al. 1999) . Briefly, cords were collected from placentas within 2 hr after delivery. The vein lumina were filled with Hank's balanced salt solution, containing antibiotic/antimycotic (penicillin, streptomycin, and fungizone). Hank's balanced salt solution-incubated cords were placed in a 4C refrigerator for 1 hr and then drained, followed by incubation with collagenase for 15 min at 37C. The HUVECs were flushed from the vein vessel together with the collagenase solution. The obtained HUVECs were cultured on plates coated with collagen. The cells were maintained in M199, 20% FBS, 20 mmol/L HEPES (pH 7.4), 1 ng/ml recombinant human fibroblast growth factor, and 90 mg/ml heparin, and antibiotics were added to the supernatant. Only cells with a maximum of six passages were used in this study.
Immunohistochemistry
IHC was performed as previously described . Briefly, sections were deparaffinized and immersed in gradient alcohol from 100% to 80%. Then, for eliminating endogenous peroxidase activity, sections were immersed in 3% hydrogen peroxide for 30 min. Antigen retrieval was performed by heating the slides at 95C in 0.01 mol/L citrate buffer (pH 6.0) for 15 min and then brought back to neutral pH with PBS. Rabbit anti-human IgG antibody (γ chain specific), mouse anti-human Igκ chain antibody, and mouse anti-human Igγ chain antibody were used to identify the IgG heavy chain, the kappa light chain, and the lambda light chain, respectively. Goat anti-human FcRn antibody was used to identify the neonatal Fc receptor. Antibodies against CD 20, CD38, CD34, and factor VIII were used to identify B lymphocytes, plasma cells, and endothelial cells. The source, dilution, and incubation condition and duration of each primary antibody are listed in Table 1 . Tissue sections were incubated with goat anti-rabbit or goat antimouse IgG labeled with horseradish peroxidase (PV9000; Zymed Laboratories, South San Francisco, CA). The color reaction was developed with a horseradish peroxidase reaction kit (3-amino-9-ethylcarbazole; Zymed Laboratories), resulting in a red reaction product. Sections were counterstained with hematoxylin. In negative controls, the primary antibody was omitted or replaced by unrelated antibodies, including antibodies to hemagglutinin (HA) and nucleoprotein (NP) of the H5N1 avian influenza virus.
Immunofluorescence
Immunofluorescence (IF) was performed as described previously by Chen and Gu (2007) . Cells were cultured on cover slides and fixed in 4% paraformaldehyde for 15 min. The slides were then immersed in 0.2% Triton X-100 for 15 min. PBS containing 10% normal goat serum was used for 60 min to block background staining. Rabbit anti-human IgG antibody (γ chain specific) or mouse anti-human CD34 antibody was used as the primary antibody. PBS was used for the control slides. After incubating with goat anti-rabbit IgG-FITC or goat anti-mouse IgG-TRITC for 30 min at room temperature, the sections were incubated with Hoechst 33342 (1:1000; Sigma, St. Louis, MO) for 15 min. The positive signals were red for TRITC or green for FITC.
In Situ Hybridization
Sense and antisense probes against mRNA of IGHG1 were prepared as previously described (Chen and Gu 2007) . A 351-nucleotide cRNA probe was produced by in vitro transcription and labeled with digoxigenin (Roche Diagnostics, Penzberg, Germany). ISH was performed as described by Gu et al. (2007) . In brief, deparaffinized tissue sections and 4% paraformaldehyde fixed cells slides were incubated with 0.1 M HCl for 10 min and immersed in 0.01 M citrate buffer (pH 6.0). Slides were heated at 95C for 20 min and cooled to room temperature. After washing in PBS buffer, sections were fixed in 4% paraformaldehyde for 10 min and then hybridized at 45C for 20 hr with the human IGHG1 antisense cRNA probe. After hybridization, slides were washed in 2× SSC plus 50% formamide for 30 min (50C) and 2× SSC twice for 15 min (37C). Sections were blocked with normal horse serum (1:100) and then incubated with alkaline phosphatase-labeled antidigoxigenin antibody (1:500; Roche Diagnostics) for 1 hr. The reaction products were colorized with nitro blue tetrazolium/5-bromo-4-choloro-3-indolyl phosphate (NBT/BCIP) (Promega, Madison, WI), resulting in a purple-blue signal. Slides were counterstained with methyl green. All solutions were prepared with diethylpyrocarbonate-treated water. In negative controls, the probe was replaced by hybridization solution, corresponding sense probes, or an irrelevant probe of similar nucleotide content and length against the HA of the H5N1 virus.
RNA Extraction and RT-PCR
Trizol Reagent (Invitrogen, Carlsbad, CA) was used to extract total RNA from full-term human umbilical cords and primary cultured HUVECs. Reverse transcription of total RNA was performed using the SuperScript III RT System (Invitrogen) following the manufacturer's instructions. All extracted RNA was treated with RQ1 RNase-free DNase (Promega). Given the fact that for the constant region of the IgG1 heavy chain (IGHG1) and the recombined variable (V), diversity (D), and joining (J) segments of the IgG heavy chain (VDJ H ), the sense and antisense primers were localized on different exons, it was easy to discriminate between transcripts and genomic DNA. For the RAG1, RAG2, kappa, and lambda Ig light chains, DNase-treated RNA and cDNA without reverse transcriptase were used to eliminate contamination by genomic DNA. Nested and semi-nested PCR was performed as described in previous studies (Huang et al. 2008; Huang et al. 2009 ). The primers used in this study are listed in Table 2 . DNA sequencing was used to confirm the identity of all PCR products. VDJ H PCR products were cloned into a pGEM-T vector (Tiangen, Beijing, China). Three randomly selected clones from the primary culture were subjected to sequencing by an ABI 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). The sequences of these three clones were then compared with published sequences in BLAST of the GenBank of the National Center for Biotechnology Information (http://www .ncbi.nlm.nih.gov/BLAST). Peripheral blood lymphocytes were used as positive controls, whereas reaction mixtures with RNA templates without reverse transcriptase and DNase-treated RNA templates served as negative controls. Water was also used as a negative control. The amplification of 18s served as an internal control.
Real-Time PCR and Quantitative Analysis
Using an Mx3000p instrument, real-time PCR was performed with SYBR Premix Ex Taq (TaKaRa Bio, Inc., Siga, Japan) according to manufacturer's instructions. Briefly, after pre-denaturation at 95C for 5 min, the amplification reaction was performed for 40 cycles of 5 sec at 94C and 40 cycles of 20 sec at 60C, followed by a final extension period of 1 min at 95C, 1 min at 60C, and 30 sec at 95C. The primers used for real-time PCR are listed in Table 2 .
The expression levels of RAG1 and RAG2 in HUVECs were compared with those in Raji and NAML-6 cell lines. For all samples, experiments were performed six times. Amplification of 18s was used for normalization. The relative expressions of RAG in the tested cell types were determined with the method of 2 −ΔΔCt (Livak and Schmittgen 2001) . 
Results
IHC
In this study, IHC was performed to detect IgG proteins with antibodies to the IgG heavy chain (Igγ) and kappa and lambda light chains (Igκ and Igλ). Positive signals were detected in cells of human umbilical vein (Fig. 1B) and arteries (Fig. 1F) , and the positive signals were located in the cytoplasm of these cells. IHC was carried out on serial sections, demonstrating colocalization of Igγ, Igκ, Igλ, and CD34 in the same cells, confirming that the IgG-positive cells were HUECs (Fig. 2, arrows). FcRn was also detected in the cytoplasm of HUECs. The signal strength was weaker, and the number of positive cells was lower than that of IgG-containing cells (Fig. 3,  arrows) . No positive signal of FcγRI, FcγRII, or FcRγIII was detected in HUECs. No CD20-positive B lymphocyte or CD38-positive plasma cell was detected in the umbilical cord tissue (Fig. 4) by careful observation. IHC with antibodies to CD34 and factor VIII, two endothelial cell markers, was carried out on serial sections, and they were found to be colocalized with each other, indicating that the IgG-positive cells were indeed endothelial cells. 
IF
IF was performed to detect the IgG protein with antibodies to Igγ. Positive signals were identified in primary cultured HUVECs (Fig. 5D-F) , and the positive signals were located in the cytoplasm of these cells. Positive CD34 signals in the cytoplasm of cultured cells indicated that these cells were indeed umbilical endothelial cells (Fig. 5A-C) .
ISH
ISH was next performed to investigate whether the IgG gene is actually expressed by HUECs. A cRNA probe against IGHG1 was employed, and positive signals were detected in endothelial cells of the umbilical vein (Fig. 1C) , umbilical artery (Fig. 1G) , and primary cultured HUVECs (Fig. 5H) . ISH showed mainly intracytoplasmic staining. IHC and ISH were performed on serial sections, and colocalization of Igγ, IGHG1 mRNA, and CD34 suggests that CD34-positive HUECs have the capacity to produce IgG (Fig. 6, arrows) .
RT-PCR and Real-Time PCR IgG Expression. To further establish that HUECs can
express IgG, RT-PCR was performed to detect IgG mRNA in the tissue samples. To exclude possible contamination by fetal lymphocytes, HUVECs from a primary culture system were also generated. Gene transcripts of IGHG1, Igκ, and Igλ were identified in tissues of human umbilical cord and primarily cultured HUVECs (Fig. 7A ). Reaction mixtures with RNA templates without reverse transcriptase and DNase-treated RNA templates served as negative controls. The successful amplification of IGHG1, Igκ, and Igλ mRNA, together with the ISH results, strongly suggests that HUECs are capable of producing IgG.
V(D)J Rearrangement.
We also detected the gene transcripts of RAG1 and RAG2 proteins, the two enzymes that together initiate the recombination of the V(D)J segments of Ig chains, both in tissues of human umbilical cord and in the primary culture of HUVECs (Fig. 7B) . Raji cell line and NALM-6 cell lines were used to represent mature B cells and pre-B cells, respectively. Real-time PCR was performed to compare the RAG expressions in HUVECs with those in mature B cells and pre-B cells. It was found that the relative expression of RAG1 in HUVECs was approximately 29 times higher than that in Raji cells (Fig. 8A) , whereas RAG2 in HUVECs was approximately 4 times higher than that in Raji cells (Fig. 8B) . The relative expressions of RAG1 (Fig. 8C ) and RAG2 (Fig. 8D ) were 205 and 637 times higher, respectively, in pre-B cells 
cells (HUECs). (A-D) Human umbilical vein endothelial cells (HUVECs) and (E-H) human umbilical arterial endothelial cells (HUAECs). On serial sections, (A, E) CD34 (arrows), (B, F) Igγ (arrows), (C, G) Igκ (arrows), and (D, H) Igλ (arrows) are coexpressed by the same HUECs of the human umbilical vein (A-D) and human umbilical artery (E-H) (bar = 10 µm). Immunohistochemistry (IHC)
: color reaction was developed with a horseradish peroxidase reaction kit (3-amino-9-ethylcarbazole), resulting in a red or a dark red color. IHC slides were counterstained with hematoxylin, resulting in a blue color. If the red IHC signals overlay with the blue staining of hematoxylin in the nucleus, they appear dark red or black. Slides were counterstained with hematoxylin.
compared to that in HUVECs. These data indicate that the expression of RAG in HUVECs is much higher than that in mature B cells but much lower than that in pre-B cells. The connective tissue adjacent to blood vessels, used as a negative control, showed no positive signal of RAG (Fig. 8E) . Gene transcripts of recombined VDJ H were also detected in tissues of umbilical cord and primary cultured HUVECs (Fig. 7A) . Sequencing of three randomly chosen VDJ H clones showed that they were highly homologous (87%) to IGHV4-59*01 (Table 3 ). These findings indicate that rearrangement of V(D)J gene segments might occur in HUECs. Contaminations by B lymphocytes and plasma cells were excluded by using primers for CD19 and CD38 in RT-PCR, respectively (Fig. 7A) .
Discussion
The present study demonstrates that HUECs can produce IgG. Both IgG proteins and IGHG1 mRNA transcripts were contamination by B lymphocytes and plasma cells, we employed a primary HUVEC culture system, in which the endogenous expression of IgG was ascertained by the techniques of IF, ISH, and RT-PCR. As umbilical cord blood is a well-known source for hematopoietic progenitor and stem cells, and stroma cells isolated from Wharton's jelly (Troyer and Weiss 2008) support the expansion of such cells, the same primary endothelial cell culturing system was also used to eliminate contamination by hematopoietic progenitor and stem cells (Conrad and Emerson 1998) . It is impossible to deduct only from the IHC results whether IgG was actually synthesized in umbilical cord endothelial cells or where it was synthesized. Positive staining of IgG could be the result of absorption or passive adherence of IgG from the surrounding environment. However, together with the results of ISH and RT-PCR obtained from umbilical cord tissue and those of ISH, RT-PCR, and IF observed in the primary culture of HUVECs, we believe that there is sufficient evidence to show that at least some of the IgG detected in the umbilical cord endothelial cells are produced by these cells themselves. The positive IgG signals sometimes were seen over the border of the endothelial cells. There are two possible explanations for this phenomenon. One is that the positive IHC signals could be attributed to serum IgG adhered to endothelial cell surfaces. The other is that IgG produced by the endothelial cells might be released into the surrounding tissue. In this study, we found no B lymphocyte or plasma cell in umbilical cord tissue. This is in agreement with a previous report by Rossi et al. (2003) , who indicated that the amount of mature B cells and plasma cells in the fetus was very small. The absence of detectable B lymphoid cells in the tissue samples we examined with a range of techniques strongly supports that the IgG we detected was not from local lymphocytes but from endothelial cells.
Traditional views hold that IgG is expressed only by B lymphocytes and plasma cells. In recent years, our group and others have shown that IgG can also be produced by non-lymphoid cell types. Initial reports described IgG expression by various epithelial cancer types (Babbage et al. 2006; Chen and Gu 2007; Qiu et al. 2003) , whereas later studies demonstrated IgG expression in non-cancerous cell types, including neurons of the CNS, testicular spermatogenic cells, epididymal epithelial cells, and epithelial cells of lactating mammary glands (Huang et al. 2008; Huang et al. 2009; Zhang S et al. 2010) .
There are two functional classes of IgG receptors-that is, the Fc gamma receptor (FcγR) with three subclasses . IHC: color reaction was developed with a horseradish peroxidase reaction kit (3-amino-9-ethylcarbazole; Zymed Laboratories, South San Francisco, CA), resulting in a red or a dark red color. IHC slides were counterstained with hematoxylin, resulting in a blue color. If the red IHC signals overlay with the blue staining of hematoxylin in the nucleus, they appear dark red or black. IHC slides were counterstained with hematoxylin. ISH: the reaction products were colorized with nitro blue tetrazolium/5-bromo-4-choloro-3-indolyl phosphate (NBT/BCIP) (Promega, Madison, WI), resulting in a purple-blue signal. ISH slides were counterstained with methyl green.
(FcγRI, FcγRII, and FcγRIII) and the neonatal Fc receptor (FcRn) (Raghavan and Bjorkman 1996) . FcγRs are chiefly present on the surface of immune cells, where they mediate effector functions (Raghavan and Bjorkman 1996) . FcRn is expressed by antigen presenting cells, as well as epithelial and endothelial cells in various organs, where they are thought to transport IgG and immune complexes across barriers and recycle IgG, extending its half-life (Roopenian and Akilesh 2007) . In the placenta, FcRn mediates IgG transfer across the syncytiotrophoblast layer (Roopenian and Akilesh 2007) . FcγRs are expressed on Hofbauer cells (Jensen and Matre 1995; Kameda et al. 1991; Sedmak et al. 1991; Stuart et al. 1989 ) and, in varying degrees, on trophoblasts and endothelial cells (Honig et al. 2005; Jensen and Matre 1995; Kameda et al. 1991; Sedmak et al. 1991; Stuart et al. 1989; Takizawa et al. 2005) , where their function is not well defined. In the present study, none of the FcγR subclasses was found to be expressed in the umbilical cord, which is in line with the results of other research groups (Groger et al. 1996; Lang et al. 1993; Sedmak et al. 1991) . However, Alberto et al. (2000) described that HUVECs bound heat-aggregated IgG, which appeared to be correlated with the expression of FcγRI, and Cines et al. (1982) reported that herpes simplex virus infection could induce expression of IgG Fc receptors on cultured HUVECs. In contrast to FcγRs, FcRn was expressed by HUECs. Its function in the umbilical cord could relate to the transport of IgG across the endothelial cells. Previous studies have demonstrated that FcRn facilitates the reverse transcytosis into the systemic circulation across the blood-retinal and bloodbrain barriers, which are both composed of capillary endothelial cells (Kim et al. 2009; Zhang Y and Pardridge 2001) . Analogously, FcRn could transport IgG produced by HUECs into the umbilical vein and arteries.
Based on the original findings made in this study, the following functional significances are conceivable. First, endogenously produced IgG could be involved in the modulation of inflammatory and infectious processes in the umbilical cord. In support of this notion, commercial human immunoglobulins were found to inhibit the proliferation of cultured HUVECs and to downregulate the cytokine-induced expression of adhesion molecules, chemokines, and cytokines in these cells (Xu et al. 1998; Yoon et al. 2006 ). In addition, locally produced IgG could play a role in the protection against maternal antibodies to paternal major histocompatibility complex (MHC) antigens. Such antibodies are generated in response to fetal lymphocytes entering the maternal bloodstream (Schroder and De la Chapelle 1972) and could in theory cross the placental barrier, causing damage to fetal cells expressing paternal MHC, including endothelial cells and immune cells. These antibodies are thought to be trapped in the placenta in the form of immune complexes composed of maternal antibodies and paternal antigens expressed on stromal and endothelial cells (Simister 1998 ). In our previous study on IgG expression in the placenta, we suggested that endogenously produced IgG might be anti-idiotypic, targeting the variable region of maternal antipaternal MHC antibodies, thus neutralizing these potential harmful antibodies (Zhao Y, Deng R, Chen Z, Korteweg C, Zhang J, Li J,Wang Yun, Wang Yongyu, Lin C, Bluth MH, Niu N, Zhuang Z, Su M, Gu J, unpublished data). Analogously, IgG produced by HUECs could also be anti-idiotypic with protective properties against antipaternal antibodies. This assumption becomes even more plausible when considering that HUECs themselves are also potential targets for antipaternal MHC antibodies, as they express MHC class I molecules constitutively at high levels (Adams, Lee, Ferguson, et al. 1994; Adams, Lee, Waldman, et al. 1994 ) and MHC class II at low levels (Krakauer 1996) , the latter of which can be increased through induction by various cytokines and microbial pathogens (Adams, Lee, Waldman, et al. 1994; Krakauer 1996) . Along the same lines, HUECs could produce asymmetrical antibodies that are incapable of eliciting immune effector functions (Margni and Binaghi 1988) . Asymmetrical antibodies are thought to play a role in sustaining pregnancy by blocking paternal MHC antigens expressed on fetal cells (Barrientos et al. 2009; Malan Borel et al. 1991; Margni and Malan Borel 1998) . Another possible function of locally produced IgG could involve growth promotion as IgG-stimulated growth of cancer cells in animal and in vitro experiments (Qiu et al. 2003) . In fact, umbilical endothelial cells produce various growth factors, including basic fibroblast growth factor, transforming growth factor beta, and platelet-derived growth factor (Hannan et al. 1988; Kourembanas and Faller 1989) . Finally, IgG derived from HUECs could play a role in the protection against invading pathogens that could threaten fetal survival.
In conclusion, umbilical endothelial cells can produce IgG, and physiological and pathological significance of this phenomenon is clearly indicated and calls for in-depth further investigation. 
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